ID
BIIB icon

Integral Derivatives’s Biogen BIIB Stock Holding History

Integral Derivatives’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		$1.75M Sell
6,400
-6,200
-49% -$1.92M 0.04% 139
2017
Q4 		$4.01M Buy
12,600
+4,200
+50% +$1.35M 0.08% 152
2017
Q3 		$2.63M Sell
8,400
-100
-1% -$29.6K 0.05% 250
2017
Q2 		$2.31M Buy
8,500
+2,100
+33% +$555K 0.05% 274
2017
Q1 		$1.75M Sell
6,400
-4,900
-43% -$1.39M 0.03% 346
2016
Q4 		$3.2M Buy
11,300
+5,800
+105% +$1.72M 0.06% 207
2016
Q3 		$1.72M Sell
5,500
-3,500
-39% -$1.04M 0.04% 304
2016
Q2 		$2.18M Sell
9,000
-3,900
-30% -$1.03M 0.05% 223
2016
Q1 		$3.36M Sell
12,900
-2,700
-17% -$713K 0.11% 138
2015
Q4 		$4.78M Buy
15,600
+3,100
+25% +$891K 0.12% 132
2015
Q3 		$3.65M Buy
12,500
+6,700
+116% +$2.21M 0.1% 168
2015
Q2 		$2.34M Buy
5,800
+400
+7% +$161K 0.06% 280
2015
Q1 		$2.28M Sell
5,400
-16,000
-75% -$6.31M 0.05% 260
2014
Q4 		$7.26M Buy
21,400
+3,600
+20% +$1.16M 0.13% 129
2014
Q3 		$5.89M Sell
17,800
-15,500
-47% -$5.11M 0.1% 160
2014
Q2 		$10.5M Buy
33,300
+7,400
+29% +$2.23M 0.18% 80
2014
Q1 		$7.92M Sell
25,900
-7,600
-23% -$2.41M 0.15% 114
2013
Q4 		$9.37M Buy
+33,500
New +$8.66M 0.13% 123

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Integral Derivatives's BIIB Position: Q1 2018 in Review

Integral Derivatives opened a new position in Biogen (BIIB) in Q1 2018: 2,095 shares worth $574K. The stake represents 0.01% of the portfolio and ranks #355 among its holdings. This is a return to the name: Integral Derivatives previously reported a position in BIIB as recently as Q1 2017.

Integral Derivatives first reported a position in BIIB in Q3 2014 and has held it in 11 quarters since. The position peaked at $4.72M in Q4 2014. 1,101 funds tracked by Wall St. Rank hold BIIB as of Q1 2018.

  • Integral Derivatives held 2,095 shares of Biogen worth $574K as of Q1 2018.
  • Biogen was a new Integral Derivatives position in Q1 2018.
  • Biogen made up 0.01% of Integral Derivatives's portfolio in Q1 2018, its #355 holding.
  • Integral Derivatives first reported a position in Biogen in Q3 2014 and has held it in 11 quarters since.
  • Integral Derivatives's Biogen position peaked at $4.72M in Q4 2014.
  • 1,101 funds tracked by Wall St. Rank held Biogen as of Q1 2018.

Based on Integral Derivatives's 13F filing for Q1 2018, filed 19 Apr 2018.